ALPINE IMMUNE SCIENCES, INC. Proceeds from Common Stock Issued
ALPINE IMMUNE SCIENCES, INC. reported Proceeds from Common Stock Issued of $161.91 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-03-20
- ALPINE IMMUNE SCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $152.21M, a 1097.38% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2023-09-30 was -$1.00K, a 100.00% decline year-over-year.
- ALPINE IMMUNE SCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $12.71M.
- ALPINE IMMUNE SCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $94.00M.
- ALPINE IMMUNE SCIENCES, INC. proceeds from issuance of common stock for fiscal 2023 was $161.91M, a 51.72% increase from fiscal 2022.
- ALPINE IMMUNE SCIENCES, INC. proceeds from issuance of common stock for fiscal 2022 was $106.72M, a 17.62% increase from fiscal 2021.
- ALPINE IMMUNE SCIENCES, INC. proceeds from issuance of common stock for fiscal 2021 was $90.73M, a 61.28% increase from fiscal 2020.
- ALPINE IMMUNE SCIENCES, INC. proceeds from issuance of common stock for fiscal 2020 was $56.26M.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-12-31 | $152.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $152.21M derived: sum of 2 quarters · filed 2024-03-20 | $161.91M 10-K · filed 2024-03-20 | |||
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $9.69M 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $9.70M 10-Q · filed 2023-08-14 | |||||
| 2022-12-31 | $12.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $106.72M derived: sum of 2 quarters · filed 2024-03-20 | $106.72M 10-K · filed 2024-03-20 | |||
| 2022-09-30 | $94.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $94.00M 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | |||||
| 2021-12-31 | -$79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $90.73M 10-K · filed 2024-03-20 | $11.93M 10-K · filed 2022-03-17 | |||
| 2021-09-30 | $90.81M 10-Q · filed 2022-11-14 | |||||
| 2020-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $56.26M derived: sum of 2 quarters · filed 2023-03-23 | $56.26M derived: sum of 3 quarters · filed 2023-03-23 | $56.26M 10-K · filed 2023-03-23 | ||
| 2020-09-30 | $56.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $56.27M derived: sum of 2 quarters · filed 2021-11-10 | $56.27M 10-Q · filed 2021-11-10 | $32.67M derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2020-07-31 | $60.00M 10-Q · filed 2020-11-12 | |||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $0.00 10-Q · filed 2020-08-11 | -$23.60M derived: sum of 3 quarters · filed 2022-03-17 | -$23.60M derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 | -$23.60M derived: sum of 2 quarters · filed 2022-03-17 | -$23.60M derived: sum of 3 quarters · filed 2022-03-17 | -$23.62M derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2019-12-31 | -$23.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$23.60M derived: sum of 2 quarters · filed 2022-03-17 | -$23.62M derived: sum of 3 quarters · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 | $23.60M 10-K · filed 2020-03-30 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$20.00K derived: sum of 2 quarters · filed 2020-11-12 | $23.60M 10-Q · filed 2020-11-12 | $23.60M derived: sum of 4 quarters · filed 2021-03-18 | ||
| 2019-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $23.60M 10-Q · filed 2020-08-11 | $23.60M derived: sum of 3 quarters · filed 2021-03-18 | $23.60M derived: sum of 4 quarters · filed 2021-03-18 | ||
| 2019-03-31 | $23.62M 10-Q · filed 2020-05-14 | $23.62M derived: sum of 2 quarters · filed 2021-03-18 | $23.62M derived: sum of 3 quarters · filed 2021-03-18 | $23.62M derived: sum of 4 quarters · filed 2021-03-18 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $0.00 derived: sum of 2 quarters · filed 2021-03-18 | $0.00 derived: sum of 3 quarters · filed 2021-03-18 | $0.00 10-K · filed 2021-03-18 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $0.00 10-Q · filed 2019-08-13 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||||
| 2017-12-31 | $0.00 10-K · filed 2020-03-30 | |||||
| 2016-12-31 | $20.00K 10-K · filed 2017-02-13 | |||||
| 2015-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | -$2.10M derived: sum of 2 quarters · filed 2017-02-13 | $78.77M 10-K · filed 2017-02-13 | |||
| 2015-09-30 | -$2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $78.77M 10-Q · filed 2016-11-07 | ||||
| 2015-06-30 | $80.88M 10-Q · filed 2016-08-02 |